Tanghua Biomedicine (Boncha Bio)

Tanghua Biomedicine, operating as Boncha Bio, is a biotech company that develops and manufactures candy-like nutritional supplements, termed "candyceuticals." The company was founded by Corina Huang, who was inspired to find an alternative to traditional pills after her grandmother experienced difficulty swallowing them following a stroke. This personal experience, coupled with her background in a customized candy business, led to the creation of Boncha Bio. The company was co-founded by individuals with expertise in pharmacy, which provided access to resources for developing their proprietary technology.

Boncha Bio's core business revolves around its Original Design Manufacturer (ODM) services, partnering with nutritional brands, pharmaceutical companies, and ingredient suppliers to design and produce high-dose, high-bioavailability supplements in a more palatable form. Their business model addresses the common issues of pill fatigue and low consumer compliance by combining nutrients into enjoyable, chewable forms. The company generates revenue by providing formula design, manufacturing services, and market-ready products.

The company's key technology is a patented, low-temperature, low-pressure manufacturing process and a nanotechnology delivery system. This process preserves the bioactivity of sensitive ingredients like probiotics and fish oil, which are often degraded by traditional candy manufacturing methods. Their products, which include candy capsules and tablets with a central filling, are designed to enhance nutrient absorption through features like their nano-nutrient vehicle (NNV) and micro-suspension technology. The candy shells can also contain prebiotics to boost the effectiveness of probiotics within the filling. Boncha Bio has established strategic partnerships, notably with dsm-firmenich, a global leader in nutrition and health, to expand its market reach, particularly in Japan and South Korea.

Keywords: candyceuticals, nutrient delivery, nutraceuticals, ODM supplements, biotechnology, drug delivery systems, pill fatigue, swallowing difficulty, high bioavailability, probiotics, nanotechnology, supplement manufacturing, functional foods, contract manufacturing, user compliance, pharmaceutical partnerships, bioactive ingredients, oral dosage forms, supplement formulation, private label supplements